IL2 and autoimmune type 1 diabetes: It has been reported that SEA can protect against type 1 autoimmune diabetes via increasing Foxp3 expression in a TGF-β-dependent manner, along with upregulating C-type lectins, IL-10, and IL-2 on dendritic cells (DC).